The board of Godrej Agrovet on Friday approved merger of its subsidiary Astec Lifesciences with itself. According to the plan, Godrej Agrovet will issue 11 fully paid-up equity shares of ₹10 each to Astech shareholders for every 10 fully paid-up equity shares.

The merger scheme will be subject to approvals from the National Company Law Tribunal, stock exchanges and SEBI. Shareholders of both companies will closely monitor further developments.